Capsaicin Patent Expiration
Capsaicin is Used for removing capsaicin from a treatment area or unintended area. It was first introduced by Averitas Pharma Inc
Capsaicin Patents
Given below is the list of patents protecting Capsaicin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Qutenza | US8821920 | Therapeutic patch for transdermal delivery of capsaicin | Mar 26, 2030 | Averitas |
| Qutenza | US9226903 | Transdermal therapeutic system comprising an adhesive layer method for siliconizing the back layer or the system and use of said back layer | Dec 15, 2028 | Averitas |
| Qutenza | US10034841 | Transdermal therapeutic system comprising an adhesive layer method for siliconizing the back layer of the system and use of said back layer |
Sep 06, 2025
(Expired) | Averitas |
| Qutenza | US10463598 | Compositions and kits for the removal of irritating compounds from bodily surfaces |
Sep 05, 2023
(Expired) | Averitas |
| Qutenza | US10869827 | Compositions and kits for the removal of irritating compounds from bodily surfaces |
Sep 05, 2023
(Expired) | Averitas |
| Qutenza | US8263059 | Compositions and kits for the removal of irritating compounds from bodily surfaces |
Sep 05, 2023
(Expired) | Averitas |
| Qutenza | US8889113 | Compositions and kits for the removal of irritating compounds from bodily surfaces |
Sep 05, 2023
(Expired) | Averitas |
| Qutenza | US6239180 | Transdermal therapeutic device and method with capsaicin and capsaicin analogs |
Nov 06, 2016
(Expired) | Averitas |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Capsaicin's patents.
Latest Legal Activities on Capsaicin's Patents
Given below is the list recent legal activities going on the following patents of Capsaicin.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 25 Feb, 2026 | US8821920 |
| Expire Patent | 27 Jan, 2025 | US10869827 |
| Expire Patent | 14 Oct, 2024 | US8263059 |
| Maintenance Fee Reminder Mailed | 12 Aug, 2024 | US10869827 |
| Maintenance Fee Reminder Mailed Critical
| 29 Apr, 2024 | US8263059 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 28 Jun, 2023 | US9226903 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 19 Apr, 2023 | US10463598 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 04 May, 2022 | US8889113 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 24 Feb, 2022 | US8821920 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 25 Jan, 2022 | US10034841 |
Capsaicin's Family Patents
Explore Our Curated Drug Screens
Clinical Trials
Recent Clinical Trials on Capsaicin:
Sometimes companies keep conducting clinical trials even after the drug's approval to discover new formulations, methods of use, or new treatment indications, so they could file for additional patents or receive regulatory exclusivity extensions, such as pediatric exclusivity, potentially delaying generic competition. Based on these recent clinical trials, generic companies need to consider the potential for new intellectual property or regulatory hurdles. These strategic moves by the drug owner might delay generic substitution or lead to additional sales of the brand drug, even after patent expiry.
